Finance

Lists
AMBBY:OTCMKTS
Ambu AS Unsponsored Denmark ADR
11,00 US$
0,00%
(0,00) 1D
30 სექ, 09:30:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMBBY...
Mkt. cap
17,12 მლრდ.
Avg. vol.
91,00
Volume
2,00
52-wk high
16,31 US$
52-wk low
9,38 US$
Beta
1,42
Shares outstanding
234,97 მლნ.
No. of employees
5 ათ.
Mkt. cap
17,12 მლრდ.
Avg. vol.
91,00
Volume
2,00
52-wk high
16,31 US$
52-wk low
9,38 US$
Beta
1,42
Shares outstanding
234,97 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
3 საათის წინ
Ambu extends pediatric clearance: what it means for Ambu stock
Profile
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services. It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse. The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
About Ambu AS Unsponsored Denmark ADR
CEOBritt Meelby Jensen
Employees5,2 ათ.
Founded1937
Headquarters-
SectorMedical device
Websiteambu.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,47 მლრდ.
1,56 მლრდ.
1,57 მლრდ.
1,64 მლრდ.
Cost of goods sold
587,00 მლნ.
611,00 მლნ.
625,00 მლნ.
665,00 მლნ.
Cost of revenue
587,00 მლნ.
611,00 მლნ.
625,00 მლნ.
665,00 მლნ.
Research and development expenses
93,00 მლნ.
94,00 მლნ.
91,00 მლნ.
87,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639,00 მლნ.
689,00 მლნ.
684,00 მლნ.
667,00 მლნ.
Operating expense
732,00 მლნ.
783,00 მლნ.
775,00 მლნ.
754,00 მლნ.
Total operating expenses
1,32 მლრდ.
1,39 მლრდ.
1,40 მლრდ.
1,42 მლრდ.
Operating income
147,00 მლნ.
164,00 მლნ.
173,00 მლნ.
221,00 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
150,00 მლნ.
153,00 მლნ.
157,00 მლნ.
203,00 მლნ.
EBT excluding unusual items
150,00 მლნ.
153,00 მლნ.
157,00 მლნ.
203,00 მლნ.
Income tax expense
35,00 მლნ.
35,00 მლნ.
36,00 მლნ.
47,00 მლნ.
Effective tax rate
23,33%
22,88%
22,93%
23,15%
Other operating expenses
-
-
-
-
Net income
115,00 მლნ.
118,00 მლნ.
121,00 მლნ.
156,00 მლნ.
Net profit margin
7,84%
7,57%
7,69%
9,51%
Earnings per share
0,43
0,44
0,46
0,59
Interest and investment income
17,00 მლნ.
4,00 მლნ.
3,00 მლნ.
6,00 მლნ.
Interest expense
-
-15,00 მლნ.
-19,00 მლნ.
-24,00 მლნ.
Net interest expenses
17,00 მლნ.
-11,00 მლნ.
-16,00 მლნ.
-18,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
183,00 მლნ.
261,00 მლნ.
271,00 მლნ.
321,00 მლნ.
Gain or loss from assets sale
2,00 მლნ.
-
-
-
AI content may include mistakes. Learn more
Google აპები